• Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–312.

    PubMed 
    Article 

    Google Scholar 

  • Bryant C, Judd FK, Hickey M. Anxiety during the menopausal transition: a systematic review. J Affect Disord. 2012;139(2):141–8.

    PubMed 
    Article 

    Google Scholar 

  • Chan CY, Lee AM, Koh YW, et al. Associations of body dissatisfaction with anxiety and depression in the pregnancy and postpartum periods: a longitudinal study. J Affect Disord. 2020;15(263):582–92.

    Article 

    Google Scholar 

  • Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40(4):219–21.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Li RX, Ma M, Xiao XR, et al. Perimenopausal syndrome and mood disorders in perimenopause: prevalence, severity, relationships, and risk factors. Medicine (Baltimore). 2016;95(32): e4466.

    Article 

    Google Scholar 

  • Cizza G, Primma S, Csako G. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab. 2009;20(8):367–73.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Tandon VR, Mahajan A, Sharma S, et al. Prevalence of cardiovascular risk factors in postmenopausal women: A rural study. J Midlife Health. 2010;1(1):26–9.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Zong Y, Tang Y, Xue Y, et al. Depression is associated with increased incidence of osteoporotic thoracolumbar fracture in postmenopausal women: a prospective study. Eur Spine J. 2016;25(11):3418–23.

    PubMed 
    Article 

    Google Scholar 

  • Bojanić I, Sund ER, Sletvold H, et al. Prevalence trends of depression and anxiety symptoms in adults with cardiovascular diseases and diabetes 1995–2019: The HUNT studies, Norway. BMC Psychol. 2021;9(1):130.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Catalano A, Martino G, Bellone F, et al. Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis. Menopause. 2018;25(10):1110–5.

    PubMed 
    Article 

    Google Scholar 

  • Núñez-Pizarro JL, González-Luna A, Mezones-Holguín E, et al. Association between anxiety and severe quality-of-life impairment in postmenopausal women: analysis of a multicenter Latin American cross-sectional study. Menopause. 2017;24(6):645–52.

    PubMed 
    Article 

    Google Scholar 

  • Hwang JH, Lee K, Choi E, et al. Sleep quality and associated factors in premenopausal, perimenopausal, and postmenopausal women in Korea: findings from the K-Stori 2016. Nat Sci Sleep. 2021;13:1137–45.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Tang R, Luo M, Li J, et al. Symptoms of anxiety and depression among Chinese women transitioning through menopause: findings from a prospective community-based cohort study. Fertil Steril. 2019;112(6):1160–71.

    PubMed 
    Article 

    Google Scholar 

  • Avis NE, Ory M, Matthews KA, et al. Health-related quality of life in a multiethnic sample of middle-aged women: study of Women’s Health Across the Nation (SWAN). Med Care. 2003;41(11):1262–76.

    PubMed 
    Article 

    Google Scholar 

  • Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause. 2018;25(10):1069–85.

    PubMed 
    Article 

    Google Scholar 

  • Natari RB, Clavarino AM, McGuire TM, et al. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies. Menopause. 2018;25(1):109–20.

    PubMed 
    Article 

    Google Scholar 

  • Enomoto H, Terauchi M, Odai T, et al. Independent association of palpitation with vasomotor symptoms and anxiety in middle-aged women. Menopause. 2021;28(7):741–7.

    PubMed 
    Article 

    Google Scholar 

  • Relationships Between Vasomotor Symptoms and Mood in Midlife Urban Chinese Women: Observations in a Prospective Study. J Clin Endocrinol Metab. 2020 Nov 1;105(11).

  • Fu JX, Luo Y, Chen MZ, et al. Associations among menopausal status, menopausal symptoms, and depressive symptoms in midlife women in Hunan Province. China Climacteric. 2020;23(3):259–66.

    PubMed 
    Article 

    Google Scholar 

  • Freeman EW, Sammel MD, Boorman DW, et al. Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiat. 2014;71(1):36–43.

    Article 

    Google Scholar 

  • Bromberger JT, Kravitz HM, Chang Y, et al. Does risk for anxiety increase during the menopausal transition? Study of women’s health across the nation. Menopause. 2013;20(5):488–95.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Tang X, Qi S, Zhang H, et al. Prevalence of depressive symptoms and its related factors among China’s older adults in 2016. J Affect Disord. 2021;2(292):95–101.

    Article 

    Google Scholar 

  • Luo Z, Li Y, Hou Y, et al. Gender-specific prevalence and associated factors of major depressive disorder and generalized anxiety disorder in a Chinese rural population: the Henan rural cohort study. BMC Public Health. 2019;19(1):1744.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Wang X, Wang L, Di J, et al. Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study. Menopause. 2021;28(11):1271–8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Kroenke K. Enhancing the clinical utility of depression screening. CMAJ. 2012;184(3):281–2.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Wang W, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2014;36(5):539–44.

    PubMed 
    Article 

    Google Scholar 

  • Volker D, Zijlstra-Vlasveld MC, Brouwers EP, et al. Validation of the patient health questionnaire-9 for major depressive disorder in the occupational health setting. J Occup Rehabil. 2016;26(2):237–44.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.

    PubMed 
    Article 

    Google Scholar 

  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    PubMed 
    Article 

    Google Scholar 

  • Wang X, Di J, Zhao G, et al. Association of nighttime sleep duration with depressive symptoms and its interaction with regular physical activity among chinese adolescent girls. Int J Environ Res Public Health. 2021; 18(21).

  • Wang Y, Mi J, Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond). 2007;31(1):177–88.

    CAS 
    Article 

    Google Scholar 

  • Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105–14.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Tao M, Shao H, Li C, et al. Correlation between the modified Kupperman index and the menopause rating scale in Chinese women. Patient Prefer Adher. 2013;7:223–9.

    Google Scholar 

  • Li L, Wu J, Pu D, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas. 2012;73(4):354–60.

    PubMed 
    Article 

    Google Scholar 

  • Cao Z. Chinese obstetrics and gynecology. Beijing, People’s Republic of China: People’s Medical Publishing House. 2014.

  • Yang D, Haines CJ, Pan P, et al. Menopausal symptoms in mid-life women in southern China. Climacteric. 2008;11(4):329–36.

    PubMed 
    Article 

    Google Scholar 

  • Zeng LN, Yang Y, Feng Y, et al. The prevalence of depression in menopausal women in China: a meta-analysis of observational studies. J Affect Disord. 2019;1(256):337–43.

    Article 

    Google Scholar 

  • Lin HL, Hsiao MC, Liu YT, et al. Perimenopause and incidence of depression in midlife women: a population-based study in Taiwan. Climacteric. 2013;16(3):381–6.

    PubMed 
    Article 

    Google Scholar 

  • Zang H, He L, Chen Y, et al. The association of depression status with menopause symptoms among rural midlife women in China. Afr Health Sci. 2016;16(1):97–104.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • de Kruif M, Spijker AT, Molendijk ML. Depression during the perimenopause: a meta-analysis. J Affect Disord. 2016;206:174–80.

    PubMed 
    Article 

    Google Scholar 

  • Mulhall S, Andel R, Anstey KJ. Variation in symptoms of depression and anxiety in midlife women by menopausal status. Maturitas. 2018;108:7–12.

    PubMed 
    Article 

    Google Scholar 

  • Juang KD, Wang SJ, Lu SR, et al. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas. 2005;52(2):119–26.

    PubMed 
    Article 

    Google Scholar 

  • Wang HL, Booth-LaForce C, Tang SM, et al. Depressive symptoms in Taiwanese women during the peri- and post-menopause years: associations with demographic, health, and psychosocial characteristics. Maturitas. 2013;75(4):355–60.

    PubMed 
    Article 

    Google Scholar 

  • Woods NF, Smith-DiJulio K, Percival DB, et al. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Menopause. 2008;15(2):223–32.

    PubMed 
    Article 

    Google Scholar 

  • Li Y, Yu Q, Ma L, et al. Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city. Maturitas. 2008;61(3):238–42.

    PubMed 
    Article 

    Google Scholar 

  • Unsal A, Tozun M, Ayranci U. Prevalence of depression among postmenopausal women and related characteristics. Climacteric. 2011;14(2):244–51.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Timur S, Sahin NH. The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause. 2010;17(3):545–51.

    PubMed 
    Article 

    Google Scholar 

  • Wang X, Wang L, Di J, et al. Prevalence and risk factors for menopausal symptoms in middle-aged Chinese women: a community-based cross-sectional study. Menopause. 2021 Aug 30.

  • Barghandan N, Dolatkhah N, Eslamian F, et al. Association of depression, anxiety and menopausal-related symptoms with demographic, anthropometric and body composition indices in healthy postmenopausal women. BMC Womens Health. 2021;21(1):192.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Brown JP, Gallicchio L, Flaws JA, et al. Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas. 2009;62(2):184–9.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Lee Y, Kim H. Relationships between menopausal symptoms, depression, and exercise in middle-aged women: a cross-sectional survey. Int J Nurs Stud. 2008;45(12):1816–22.

    PubMed 
    Article 

    Google Scholar 

  • Sternfeld B, Guthrie KA, Ensrud KE, et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014;21(4):330–8.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar 

  • Clayton A, Guico-Pabia C. Recognition of depression among women presenting with menopausal symptoms. Menopause. 2008;15(4):758–67.

    PubMed 
    Article 

    Google Scholar 

  • Gallicchio L, Schilling C, Miller SR, et al. Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res. 2007;63(3):263–8.

    PubMed 
    Article 

    Google Scholar 

  • Bosworth HB, Bastian LA, Kuchibhatla MN, et al. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med. 2001;63(4):603–8.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338(4):209–16.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Stearns V, Beebe KL, Iyengar M, et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003;289(21):2827–34.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Schober CE, Ansani NT. Venlafaxine hydrochloride for the treatment of hot flashes. Ann Pharmacother. 2003;37(11):1703–7.

    CAS 
    PubMed 
    Article 

    Google Scholar 

  • Topics #Alternative #Beauty #Health Care #Medicine #Popular Diets